Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke

Laboratory Investigation

Volumn 79, Issue 4, 1999, Pages 417-425

  Issa, Razao ^a   Krupinski, Jerzy ^c   Bujny, Tomasz ^c   Kumar, Shant ^b   Kaluza, Jozef ^c   Kumar, Pat ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BRAIN BLOOD FLOW; BRAIN TISSUE; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE REGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; BRAIN; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, MITOGEN; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032937146     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A., Wilks AF, Alitalo K, and Stacker SA (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548-553.
2. Alvarez JA, Baird A, Tatum A, Daucher J, Chorsky R, Gonzalez AM, and Stopa EG (1992). Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms. Mol Pathol 5:303-307.
3. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, and Unger EF (1994). Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183-2189.
4. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, and Isner JM (1995). Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vase Surg 21:314-324.
5. Bradford M (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein dye binding. Anal Biochem 72:248-254.
6. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, and Isner JM (1996). Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97:469-476.
7. Christov C, Adle-Biassette H, LeGuerinel C, Natchev S, and Gherardi RK (1998). Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas. Neuropathol Appl Neurol 24:29-35.
8. Eke A, Conger C, Anderson M, and Garcia J (1990). Histological assessment of neurones in rat models of cerebral ischemia. Stroke 21:299-304.
9. Ferrara N and Davis-Smyth T (1997). The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
10. Fischer S, Knoll R, Renz D, Karliczek GF, and Schaper W (1997). Role of adenosine in the hypoxic induction of vascular endothelial growth factor in porcine brain derived microvas, cular endothelial cells. Endothelium 5:155-165.
11. Hatva E, Kaipainen A, Mentula P, Jaaskelainen J, Paetau A, Haltia M, and Alitalo K (1995). Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146:368-378.
12. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh E, and Symes JF (1996). Clinical evidence of angiogenesis after arterial gene transfer of rhVEGF in patient with ischemic limbs. Lancet 348:370-374.
13. Jakeman LB, Winer J, Bennett GL, Altar CA, and Ferrara N (1992). Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253.
14. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, and Alitalo K (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298.
15. Kaplan JB, Sridharan L, Zaccardi JA, Dougher-Vermazen M, and Terman BI (1997). Characterization of a soluble vascular endothelial growth factor receptor immunoglobulin chimera. Growth Factors 14:243-256.
16. Kremer C, Breier G, Risau W, and Plate KH (1997). Upregulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res 57:3852-3859.
17. Krupinski J, Issa R, Bujny T, Slevin M, Kumar P, Kaluza J, and Kumar S (1997). A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in man. Stroke 28:56-57.
18. Krupinski J, Kaluza J, Kumar P, Kumar S, and Wang JM (1994). Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25:1794-1798.
19. Kuzuya M, Satake S, Esaki T, Yamada K, Hayashi T, Nito M, Asai K, and Iguchi A (1995). Induction of angiogenesis by smooth muscle cell-derived factor: Possible role in neovascularization in atherosclerotic plaque. J Cell Physiol 165: 658-667.
20. Ladoux A and Frelin C (1993). Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 195:1005-1010.
21. Ment LR, Stewart WB, Fronc R, Seashore C, Mahooti S, Scaramuzzino D, and Madri JA (1997). Vascular endothelial growth factor mediates reactive angiogenesis in the postnatal developing brain. Dev Brain Res 100:52-61.
22. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, and Berse B (1994). Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145:574-584.
23. Nag S, Takahashi JL, and Kilty DW (1997). Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J Neuropathol Exp Neurol 56:912-921.
24. Park JE, Chen HH, Winer J, Houck KA, and Ferrara N (1994). Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269: 25646-25654.
25. Pekala P, Marlowe M, Huvelman D, and Connolly D (1990). Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-α, but not by insulin. J Biol Chem 265:18051-18054.
26. Plate KH, Breier G, Weich HA, Mennel HD, and Risau W (1994). Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 15:520-529.
27. Qu-Hong, Nagy JA, Senger DR, Dvorak HF, and Dvorak AM (1995). Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem 43:381-389.
28. Schweiki D, Itin A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359:843-845.
29. Stavri GT, Hong Y, Zachary IC, Breier G, Baskerville PA, Yla-Herttuala S, Risau W, Martin JF, and Erusalimsky JD (1995). Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 358:311-315.
30. Takahashi M, Kawabe T, Ogura K, Maeda S, Mikami Y, Kaneko N, Terano A, and Omata M (1997). Expression of vascular endothelial growth factor at the human gastric ulcer margin and in cultured gastric fibroblasts: A new angiogenic factor for gastric ulcer healing. Biochem Biophys Res Commun 234:493-498.
31. Tanaka R, Miyasaka Y, Yada K, Ohwada T, and Kameya T (1995). Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model. Stroke 26:2154-2159.
32. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, and Gospodarowicz D (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187: 1579-86.
33. Yang R, Bunting S, Ko A, Keyt BA, Modi NB, Zioncheck TF, Ferrara N, and Jin H (1998). Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J Pharmacol Exp Ther 284:103-110.